In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Calculate the 10-year risk of fatal and non-fatal cardiovascular disease events of your patients

 

Discover HeartScore

HeartScore is now updated with the SCORE2 and SCORE2-OP algorithms with recommendations for physicians and patients, from the 2021 ESC Guidelines on CVD Prevention in Clinical Practice.

Calculate 10-year risk of fatal and non-fatal cardiovascular disease events

No log-in required

This new release is available in English, for four risk regions: find out which risk model applies for your country.

This Content Component encountered an error
This Content Component encountered an error
This Content Component encountered an error
This Content Component encountered an error

 

We are currently raising funds to deploy this update in HeartScore national versions.

The HeartScore Full Version with data storage functionalities is discontinued as of April 2022.

 Testimonials from National Coordinators for CVD Prevention

Professor Margus Viigimaa, Estonia

"HeartScore is a convenient and useful tool for cardiologists and other physicians wishing to assess cardiovascular risk, plan and evaluate tailored risk factor intervention in high CVD risk subjects. It is technically well done and easy to use."

Professor Mirza Dilic, Bosnia & Herzegovina

"We expect to significantly improve the quality of the prevention programmes in general practice, outpatient clinics, general practice offices, i.e. in everyday clinical practice. We can improve standard care across the country and be sure that patients receive the best possible advice and be sure that our advice is fully understandable for a large majority of our patients. HeartScore will help us reduce morbidity and mortality in the overall population, but especially in a very important group of patients – asymptomatic high-risk individuals and their families."

This Content Component encountered an error